Pirfenidone restores metabolic hormones and cardiac autophagy via p-AMPK in MASH. [PDF]
López-Cifuentes D +4 more
europepmc +1 more source
Correction to "Tissue-Microenvironment-Responsive Self-Assembling Peptide Nanoshells Boost Pirfenidone Efficacy in the Treatment of Liver Fibrosis". [PDF]
europepmc +1 more source
Evaluation of Pirfenidone for the Treatment of Acute Respiratory Distress Syndrome: A Case Report. [PDF]
Brown CC +4 more
europepmc +1 more source
Comparative efficacy and safety of monotherapy and combination pharmacotherapies for idiopathic pulmonary fibrosis: a network meta-analysis of randomized controlled trials. [PDF]
Xu J, Liu X, Liang X, Cai X, Qian W.
europepmc +1 more source
Combination antifibrotic and immunosuppressive therapy in progressive fibrosing ILD. [PDF]
Fischer R, Abdul Rehman K.
europepmc +1 more source
A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation. [PDF]
Perch M +10 more
europepmc +1 more source
Pirfenidone Suppresses Liver Fibrosis Through Inhibition of TGF-β-Associated Lipid Metabolic Remodeling in Hepatic Stellate Cells. [PDF]
Lan Y +7 more
europepmc +1 more source
Pirfenidone Ameliorates Paraquat-Induced Epithelial-Mesenchymal Transition via miR-9-8974-5p/RGS2 Axis. [PDF]
Wang P +9 more
europepmc +1 more source
Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications. [PDF]
Previtero D +12 more
europepmc +1 more source
Pirfenidone-Induced Lichen Planus Pigmentosus in a Patient with Idiopathic Pulmonary Fibrosis. [PDF]
Mondal A, Palit A, Paul KK.
europepmc +1 more source

